# Ahmedabad-based drug maker Torrent Pharma has taken a significant early lead in the generic semaglutide market.

*biotech · news · 2026-05-07 · The Economic Times*

## Key points

- Torrent Pharma captured nearly 38% of the generic semaglutide market within a month of launch.
- Torrent is the only Indian company offering semaglutide in oral, reusable, and disposable injectable forms.
- Torrent's oral semaglutide uses a hybrid technology that does not violate Novo Nordisk's Rybelsus patent.
- Demand for Torrent's oral semaglutide is causing shortages at pharmacies despite recent market entry.
- Semaglutide could account for 80% of India's GLP1 market within the next 12-24 months.

**Companies:** Torrent Pharma, Zydus Lifesciences, Dr Reddy's Laboratories, Lupin, Alkem, Eris, Sun Pharma, USV
**Countries:** India

[Read the full story on The Economic Times](https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/semaglutide-race-torrent-grabs-38-market-share/articleshow/130919758.cms)

---

Canonical: https://newsio.io/n/9666e811-7bce-4c66-8899-0f3de2e44e39/ahmedabad-based-drug-maker-torrent-pharma-has-taken-a-significant-early-lead-in
Summarized by Newsio from The Economic Times. https://newsio.io/how-it-works